Coave Therapeutics raised €21M in a Series B round in Jul 2021. The company is based in Saint-jacques-de-la-lande, France. Investors in the round: eureKARE, Fund plus, Go Capital and 7 others. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €21M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
